GOLDMAN SACHS GROUP INC - ACURA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACURA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$11,000
-42.1%
11,184
-73.3%
0.00%
Q4 2014$19,0000.0%41,888
+75.3%
0.00%
Q3 2014$19,000
-29.6%
23,899
-3.4%
0.00%
Q2 2014$27,000
-15.6%
24,752
+12.4%
0.00%
Q1 2014$32,000
-13.5%
22,029
-0.9%
0.00%
Q4 2013$37,000
-44.8%
22,230
-37.1%
0.00%
Q3 2013$67,000
+52.3%
35,360
+50.7%
0.00%
Q2 2013$44,000
+29.4%
23,465
+118.0%
0.00%
Q2 2012$34,00010,7620.00%
Other shareholders
ACURA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 10,294,886$16,396,0008.24%
FAS Wealth Partners, Inc. 91,983$154,0000.09%
CORTLAND ASSOCIATES INC/MO 39,050$65,0000.01%
Tower Research Capital LLC (TRC) 37,812$63,0000.01%
Mariner, LLC 52,018$87,0000.01%
OPPENHEIMER & CO INC 55,000$92,0000.00%
Weiss Multi-Strategy Advisers LLC 75,000$125,0000.00%
COMMERCE BANK 89,400$150,0000.00%
Spark Investment Management LLC 12,300$20,0000.00%
Hodges Capital Management Inc. 28,950$48,0000.00%
View complete list of ACURA PHARMACEUTICALS INC shareholders